{"id":999785,"date":"2026-09-02T09:02:23","date_gmt":"2026-09-02T13:02:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/"},"modified":"2026-09-02T09:02:23","modified_gmt":"2026-09-02T13:02:23","slug":"solid-biosciences-to-participate-at-upcoming-investor-conferences-12","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/","title":{"rendered":"Solid Biosciences to Participate at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CHARLESTOWN, Mass., Sept.  02, 2026  (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB) (the \u201cCompany\u201d or \u201cSolid\u201d), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>2026 Cantor Global Healthcare Conference<br \/><\/strong>Bo Cumbo, President and CEO, and Gabriel Books, M.D., Chief Medical Officer, will participate in a fireside chat on Wednesday, September 9, 2026, at 3:55 p.m. ET. A live webcast of the presentation will be available by clicking <a href=\"https:\/\/sqps.onstreamsecure.com\/origin\/enliven\/players\/EnlivenPlayer.html?customerId=22&amp;eventId=51678424&amp;checkCompany=1&amp;checkEmail=1&amp;checkName=1\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>2026 Citi Biopharma Back to School Conference<\/strong><br \/>\n          <br \/>Mr. Cumbo and\u00a0Dr. Brooks will participate in a fireside chat on Thursday, September 10, 2026, at 3:00 p.m. ET. A live webcast of the presentation will be available by clicking <a href=\"https:\/\/kvgo.com\/2026-biopharma-conference\/solid-biosciences-sep-2026\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>H.C. Wainwright 28th Annual Global Investment Conference <\/strong><br \/>\n          <br \/>Mr. Cumbo will participate in a fireside chat on Monday, September 14, 2026, at 1:00 p.m. ET. A live webcast of the presentation will be available by clicking <a href=\"https:\/\/journey.ct.events\/view\/33b22bc7-0e74-4c0f-a953-2791f9155b2f\" rel=\"nofollow\" target=\"_blank\">here<\/a>. <\/p>\n<\/li>\n<\/ul>\n<p>Each fireside chat webcast will also be available on the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S8aYt-nT78ZQyqELfPvR72JD6KHjE3qzUUm-Wo08T9PBwJCD_R2BfoaDIdvgUMsgWPjOddE1v_lXgrWH0e4ka_1ToYnDAVsY4atDqgzAEV8nd1WgWizB7TVOBHTwSyoy2qFs0TdjfJA7wtOzLad7MM71ZGY9LumawnXOUsT84RA26DrcCfrdqGyWd8Be_2zP946JlRPQw6Us7Aa0ljgwtAdzR0I36pj4X1O1N4YIFWhNmeu7r3Usq6KXoxySa9CedurLbDMu241VNNvTc5nNhQ==\" rel=\"nofollow\" target=\"_blank\">Events<\/a>\u00a0page of the Investors section of the Company website. Webcast replays will be archived for 90 days on the Events page.<\/p>\n<p>\n        <strong>About\u00a0Solid Biosciences<\/strong><br \/>\n        <br \/>Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including SGT-003 for Duchenne muscular dystrophy (Duchenne), SGT-212 for Friedreich\u2019s ataxia (FA), SGT-501 for catecholaminergic polymorphic ventricular tachycardia (CPVT), SGT-601 for TNNT2-mediated dilated cardiomyopathy and additional fatal, genetic cardiac diseases. The Company is also focused on developing innovative libraries of genetic regulators and other enabling technologies with promising potential to significantly impact gene therapy delivery cross-industry. Solid is advancing its diverse pipeline and delivery platform in the pursuit of uniting experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted by Duchenne, Solid\u2019s mission is to improve the daily lives of patients living with devastating rare diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GrMWLgXJsgdSrYRj50oo5H8jVSZvAixxjiPA1DFfaSSOHwW2LvUBqGRXO5kudLMiUsmH7xfHSEQyEzM0blCVMGw9q3UoL1mygJ-BdbjIsrw=\" rel=\"nofollow\" target=\"_blank\">www.solidbio.com<\/a> and follow us on LinkedIn at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q6E8Ap9lz3X-1Ama4Or9m8sHz2Zzu77o6ufTHRu40oD7-1TRoBeXcLKVKM47RZs8GKss-Xh9WBiUnfrG0svUHZnLF32KV8ZWgNzqpm-X3Nw8cq_RNybnmThercHHU9dc\" rel=\"nofollow\" target=\"_blank\">Solid Biosciences<\/a> and X at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7waKPb7OLg_VPYe98iF5N8ecTXLD5WMj5_ABuvgBkUWTLsCxYV40y2UHm2YMUZ4wgeAbVvr_TSF0SrmDvar9hQ==\" rel=\"nofollow\" target=\"_blank\">@Solid_Bio<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Nicole Anderson<br \/>Senior Director, Investor Relations and Corporate Communications<br \/>Solid Biosciences Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ndb7td14V1YoGuSzOPnRqmG_eGX3xCoMF297QXYJqn-KNbr_YSJ25NqJWbZE4J5IdI7uas301lOmv__uAXAfQiymMlsbgGH44nirGEk5PyCJNXPzY3uZMfnFQ1IMO8IzXyhfhfhy0VCnJYwrE8JiDg553YsigdvKZ4FXhtIAYwTlvAq6PeUd0X_1GvlfFOh1X0hwukgEwLaBvj33bA4T_ORnkVOyAl81EFq2BxlkqBztAAaip7xr1SXvogNS0cI6BQjpEuNF5NcfUdRalLm6VXLYS0Xz5NsmfJyVI5E0yYXK7jJHWaeTlqYdT4H5cnnqjRUDzoevabPqexmnadF7pau2l-mdWgKPejKQol_kfYA42DIO-kb7OM0bjmPlOBwEMm-1s2EYYKRbvELVhY1JkGi8c4VQ40xG9l-ufooRQXmNaPv8O2KUsLYjPsIx4QCE_SGTTO-jDiIXDHEpCLMUIcUpVlzXXfUcbdEqXvWz_QPZSyTSu96PubcquiIh8E_a-Q0yCXwCxjPE2M9P9xM8jAqe8TRfIy_RD5yI05BAKkzSehEgZs-u75lleyj9L2DCTVlcr3lP6Isx7sA32FpjxdnarGnAXNxIDT06vXtqDLR8uNWRQMqEExuLhMDgDuDbZavDhiRW0U4Cpnnr3kuJnMMeXeMsNrMpR1SwQgCkY5BKKuy-D1AngJ-3XsegCjcPLvvsWx_dnERut7bS3I4c1xfbzGEaxFnN-atOC_zHHiYT2siW55usTAjPH7g7vqXmBtLGH2Ew3ur7XJu0dDYekpECT4UiGHCxfuL1TYws3K3QXvbkl609Ej1S29qCfCNQVX9ZOAXreufxRtFH7EqUYQtTBc66M5uUP6bZ6VHoewC8eJSdvgGBP2N-U3lg7Liziu_2WmshZvb7_TdLxYxkK8dts4r1e_sAT4R5hjO30nfab1XMofmTTO9EobwNgPxPuBmLOLxD81goBtp2ADBiuxQKsHIhdjLJLIYFwO9GzMWFObvQDAhPqhYf-rIAC0qe0L9dxk2ybaJVpSCMA69iuRHym6M28gQqjadG2YNj_-EbPU_5EKEUj1ihRSz1cLU57yiBJx1viEwfDWM1TkmDCg6IBtHN1Ao4PmUwjMEjTlqF6kIPLdFLiLBRZvhe9zSXaJeZkWleT9ePWgWGrVsBJpxMCtaQLbYLYf0hnA3L35dBb7FEQCHqfqyogJpGXyALsKeVmBtmeTQraYHeEDQri1Xug_dxqxcxF4hwQhSgapPTHuIn4g7Wv3iZUo6mnL_NYCuBtX003l860GxiQU2NNM_rpGX7-RyPOh68pZuVfQstk-eyMWj9_tG0XZjqIEljlVL0x92oWdJgcG2d5dxKSeCTpeZq6KT8860JuhPHyDAzvep2vIMvv2F0AcL5sfNKMEFoD22pDplSWKMmntcemj7YlZEXUJT2NmrLDPj7sNc-46Y3qr2snl41KDSPexQlwKjvTAR_gUaJq2HTRxhvzp5_VFzyUtEjGrFlp1XBYKFq7HZ4LrxAp8Lf-rsNszCTZE70dAk2l7Yr_KgwJ4i9DQGPsjxBqlsRDFmGX-Vzr9__MjWPVKlANEYy2HjCvYKkOBRPiqsrKlKH-DQvwqLWSAHzI2odxOprdFoVte59Lw9njRv-2z0ZDKVCwoPz96FBkX66zYHvnpBwDO7o_7c3_DfmrA60QdpEm3g_J6TE9szW_5keKbO--kYSguioPg-kkuqUCN---T2dvEOj9fbglg==\" rel=\"nofollow\" target=\"_blank\">investors@solidbio.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Amir\u00a0Khan<br \/>Corporate Affairs Practice<br \/>Syneos Health<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9zOH44oZFV8cKd_N9asmXITDnwQYFNhaG6rCfI7yNMhbgOM1rc7NrS1pHt6bYuTw8-RZxODajaJpGV07D-vjpRblnQ2BT7zXLSI00VmN6kowjqx02j01HTenB2MZuunZ\" rel=\"nofollow\" target=\"_blank\">amir.khan@Syneoshealth.com<\/a><br \/>(347) 249-0230<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWNlYzJkMGMtMDU2MC00Y2VjLWE2MTItOWFhYjRjZDQ3NjBkLTExMDI3NjgtMjAyNi0wOS0wMi1lbg==\/tiny\/Solid-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHARLESTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB) (the \u201cCompany\u201d or \u201cSolid\u201d), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences: 2026 Cantor Global Healthcare ConferenceBo Cumbo, President and CEO, and Gabriel Books, M.D., Chief Medical Officer, will participate in a fireside chat on Wednesday, September 9, 2026, at 3:55 p.m. ET. A live webcast of the presentation will be available by clicking here. 2026 Citi Biopharma Back to School Conference Mr. Cumbo and\u00a0Dr. Brooks will participate in a fireside chat on Thursday, September 10, 2026, at 3:00 p.m. ET. A live webcast of the presentation will be available by clicking here. H.C. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Solid Biosciences to Participate at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-999785","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHARLESTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB) (the \u201cCompany\u201d or \u201cSolid\u201d), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences: 2026 Cantor Global Healthcare ConferenceBo Cumbo, President and CEO, and Gabriel Books, M.D., Chief Medical Officer, will participate in a fireside chat on Wednesday, September 9, 2026, at 3:55 p.m. ET. A live webcast of the presentation will be available by clicking here. 2026 Citi Biopharma Back to School Conference Mr. Cumbo and\u00a0Dr. Brooks will participate in a fireside chat on Thursday, September 10, 2026, at 3:00 p.m. ET. A live webcast of the presentation will be available by clicking here. H.C. &hellip; Continue reading &quot;Solid Biosciences to Participate at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T13:02:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Solid Biosciences to Participate at Upcoming Investor Conferences\",\"datePublished\":\"2026-09-02T13:02:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/\"},\"wordCount\":367,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/\",\"name\":\"Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc=\",\"datePublished\":\"2026-09-02T13:02:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solid Biosciences to Participate at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/","og_locale":"en_US","og_type":"article","og_title":"Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk","og_description":"CHARLESTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB) (the \u201cCompany\u201d or \u201cSolid\u201d), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences: 2026 Cantor Global Healthcare ConferenceBo Cumbo, President and CEO, and Gabriel Books, M.D., Chief Medical Officer, will participate in a fireside chat on Wednesday, September 9, 2026, at 3:55 p.m. ET. A live webcast of the presentation will be available by clicking here. 2026 Citi Biopharma Back to School Conference Mr. Cumbo and\u00a0Dr. Brooks will participate in a fireside chat on Thursday, September 10, 2026, at 3:00 p.m. ET. A live webcast of the presentation will be available by clicking here. H.C. &hellip; Continue reading \"Solid Biosciences to Participate at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-02T13:02:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Solid Biosciences to Participate at Upcoming Investor Conferences","datePublished":"2026-09-02T13:02:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/"},"wordCount":367,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/","name":"Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc=","datePublished":"2026-09-02T13:02:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTQ5OCM3ODEwNzUzIzIwOTExOTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-12\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Solid Biosciences to Participate at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=999785"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999785\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=999785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=999785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=999785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}